Ossiam’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
2,688
-471
-15% -$237K 0.02% 202
2025
Q4
$1.47M Buy
3,159
+207
+7% +$96.1K 0.03% 181
2025
Q3
$1.26M Sell
2,952
-318
-10% -$123K 0.02% 415
2025
Q2
$1.25M Sell
3,270
-1,374
-30% -$495K 0.01% 349
2025
Q1
$1.6M Buy
4,644
+299
+7% +$96.2K 0.02% 255
2024
Q4
$1.3M Buy
4,345
+467
+12% +$163K 0.02% 313
2024
Q3
$1.58M Sell
3,878
-1,301
-25% -$476K 0.03% 262
2024
Q2
$1.66M Buy
5,179
+974
+23% +$316K 0.03% 245
2024
Q1
$1.4M Buy
4,205
+423
+11% +$129K 0.02% 315
2023
Q4
$1.02M Buy
3,782
+469
+14% +$116K 0.02% 359
2023
Q3
$815K Buy
3,313
+355
+12% +$97.1K 0.01% 382
2023
Q2
$898K Sell
2,958
-26,979
-90% -$7.5M 0.02% 322
2023
Q1
$7.89M Buy
29,937
+28,509
+1,996% +$7.24M 0.16% 100
2022
Q4
$343K Hold
1,428
0.01% 409
2022
Q3
$262K Buy
+1,428
New +$284K 0.01% 419
2022
Q2
Sell
-1,919
Closed -$481K 461
2022
Q1
$481K Buy
+1,919
New +$482K 0.01% 313
2019
Q1
Sell
-565
Closed -$70K 298
2018
Q4
$70K Buy
+565
New +$75.8K 0.01% 245

Other funds holding HCA

Ossiam's HCA Position: Q1 2026 in Review

Ossiam reduced its HCA Healthcare (HCA) stake by 15% in Q1 2026, selling an estimated $237K and leaving 2,688 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #202.

Ossiam first reported a position in HCA in Q4 2018 and has held it in 17 quarters since. The position peaked at $7.89M in Q1 2023. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Ossiam held 2,688 shares of HCA Healthcare worth $1.27M as of Q1 2026.
  • Ossiam sold 471 HCA Healthcare shares in Q1 2026, an estimated $237K.
  • HCA Healthcare made up 0.02% of Ossiam's portfolio in Q1 2026, its #202 holding.
  • Ossiam first reported a position in HCA Healthcare in Q4 2018 and has held it in 17 quarters since.
  • Ossiam's HCA Healthcare position peaked at $7.89M in Q1 2023.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.